Search
Menu
Lumencor Inc. - ZIVA Light Engine 3-24 LB

Spectranetics Wins FDA Approval for Smallest Catheters

Facebook X LinkedIn Email
COLORADO SPRINGS, Colo., July 27 -- The Spectranetics Corp. has received the approval of the Food and Drug Administration to market its smallest Point 9 catheters with higher laser parameters (i.e., more laser energy). Bench studies and clinical experience in Canada demonstrated to the FDA that some difficult-to-treat lesions -- some that could not previously be treated in a minimally invasive fashion -- can be safely and effectively treated with higher laser parameters delivered through the company's smallest and most maneuverable catheters.

"We were delighted to receive FDA approval for the modified Point 9 catheters so quickly," said Joseph A. Largey, president and CEO of Spectranetics. "Before they can be used, various upgrades must be performed on different generations of CVX-300 lasers in the field. We initially plan to test market the laser upgrades and higher-performance catheters in a small number of accounts."

Rocky Mountain Instruments - Custom Assemblies MR

Published: July 2001
News & Features

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.